Our Institutional Funds

For 20 years, Seventure Partners has developed strong expertise in the creation and management of investment vehicles specializing in the financing of innovative companies, particularly in France and other countries in Europe, for individual or institutional subscribers.

Seventure Partner’s funds take ownership interests in companies operating in Seventure Partners’s two areas of expertise: Life sciences and Digital technologies. Seventure Partners has also developed expertise in the management of Professional Private Equity Funds (FPCI, ex-FCPR, or Sicar) for French and international investors.

The first liquidated FPCI, Spef Pre-IPO, enabled its subscribers to achieve an internal rate of return (IRR) of 31%. Since 2013, three funds have been offered to institutional investors :

Read less Read more

Health For Life Capital TM

Health for Life Capital™, is the first European investment vehicle to support the microbiome revolution in the areas of health and nutrition through capital financing.

This €160 million fund attracted financial investors and family offices, as well as prestigious strategic industrial investors (Danone, Novartis, Bel, Tereos, Lesaffre, Tornier, etc.) and entrepreneurs.


Health for Life Capital™ is managed by the Life Sciences team of Seventure Partners, led by Isabelle de Cremoux.

Health for Life Capital™, invests in innovative companies with strong growth potential. It mainly invests in Europe, but also looks to North America and Asia; at any stage of maturity, including the seed stage, venture capital, pre-IPO and late stage or innovative growth capital.

Seventure Partners has demonstrated true global leadership in the areas of convergence of medicine and food and has accumulated recognized expertise in the field of nutrition, microbiology and its applications. Recent discoveries on the microbiome constitute a true technological revolution impacting both the agro-food, pharmaceutical, medical instrumentation and diagnostic industries.

Read less Read more

Digital Opportunities

The Digital Opportunities Fund finances the innovative companies identified as having strong growth potential, mainly in France and Germany, and operating in the field of digital technologies: SaaS software and solutions, innovative services, and, last but not least, Fintech / Insurtech.

Since 1997, Seventure Partners’ Digital technologies team has acquired solid expertise in these three sectors by financing the development of companies such as TalentSoft, Prestashop or Conject for Saas software and solutions, and Recommerce or Studitemps for Innovative services.

As of 2003, Seventure had anticipated the Fintech / Insurtech wave by investing in AssurOne (sold to Anacap Group), then in Retailo (sold to Blackhawk Network), or more recently in Payleven.

Digital Opportunities is managed by the current Digital Technologies team headed by David Manjarres.

Seventure Partners’membership in Groupe BPCE, its access to the numerous expertises present at Natixis and its proximity to the Group’s distributing networks constitute a virtuous circle to identify, support and enhance the most relevant fintechs and insurtech.

Read less Read more

Quadrivium 1 Seed Fund

The Quadrivium 1 Seed Fund is a fund of €56.1 million, created in November 2013 managed by Seventure Partners with a dedicated investment team composed of two Partners, Cédric Favier and Philippe Tramoy, and one Venture Partner, Didier Piccino.


The Quadrivium 1 Seed Fund finances  French start-up companies linked to the twelve academic and university institutions that are partners of this fund (UPMC, University Paris II, University of Paris IV, National Museum of Natural History, IRCAM, ENSCI, University of Compiègne, CNRS, Institut Curie, Pierre Gilles de Gennes Foundation, Fondation Voir et Entendre or Paris Sciences et Lettres), in the field of Digital technologies and Life sciences (with the exception of the microbiome).

For Digital technologies companies that are at a more advanced stage of development or not related to our twelve academic partners, please contact the Digital technologies team (01 58 19 22 70 – contact@seventure.fr).

For Life sciences companies outside France at any stage of maturity, microbiome companies in any geography and stage of development  and French companies  at a more advanced stage of development, or not related to our 12 academic partners, please contact the Life sciences team (01 58 19 22 70 – contact@seventure.fr).

Read less Read more

By continuing your browsing on this site, you accept the use of cookies to carry out statistics of anonymous visits. Read more

Authorize Refuse